Customized versus population fetal growth norms and adverse outcomes associated with small for gestational age infants in a high-risk cohort

Hind N. Moussa, Zhao Helen Wu, Yimei Han, Luis Pacheco, Sean C. Blackwell, Baha M. Sibai, George Saade, Maged Costantine

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective To compare population versus customized fetal growth norms in identifying neonates at risk for adverse perinatal and neonatal outcomes (AOs) associated with small for gestational age (SGA) in high-risk women. Design Secondary analysis to a multicenter treatment trial of pregnant women at high risk for preeclampsia using low-dose aspirin versus placebo. The associations between SGA by population (SGApop) and customized (SGAcust) norms and AOs were evaluated. Results A total of 2,289 mother/infant pairs were included in the analysis. The rates of SGA in the aspirin and placebo groups were similar by the customized (22.8% vs 23.9%; p=0.55) or population (8.7% vs 7.5%; p=0.54) norms; however, they were lower using population norms compared with customized norms (p<0.001). SGAcust, but not SGApop, was associated with spontaneous preterm birth (odds ratio [OR]: 1.44, 95% confidence interval [CI]: 1.15-1.81; p<0.001), preterm premature rupture of membranes (OR 1.42 95% CI 1.05-1.92; p=0.02), and cesarean delivery (OR: 1.35, 95% CI: 1.11-1.64; p=0.002). Both SGAcust and SGApop were associated with the composite neonatal outcome, indicated preterm delivery before 32, 35, and 37 weeks, oligohydramnios, fetal distress, as well as decreased risk of oxygen requirement. Neither was associated with preeclampsia. Conclusion Customized approach for assessment of fetal growth was associated with higher SGA rates and better identification of SGA neonates at risk for AOs.

Original languageEnglish (US)
Pages (from-to)621-626
Number of pages6
JournalAmerican Journal of Perinatology
Volume32
Issue number7
DOIs
StatePublished - Sep 28 2014

Fingerprint

Small for Gestational Age Infant
Population Growth
Fetal Development
Gestational Age
Population
Odds Ratio
Confidence Intervals
Pre-Eclampsia
Aspirin
Placebos
Newborn Infant
Oligohydramnios
Fetal Distress
Premature Birth
Multicenter Studies
Pregnant Women
Mothers
Oxygen

Keywords

  • adverse outcomes
  • customized
  • fetal growth restriction
  • high risk

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Customized versus population fetal growth norms and adverse outcomes associated with small for gestational age infants in a high-risk cohort. / Moussa, Hind N.; Wu, Zhao Helen; Han, Yimei; Pacheco, Luis; Blackwell, Sean C.; Sibai, Baha M.; Saade, George; Costantine, Maged.

In: American Journal of Perinatology, Vol. 32, No. 7, 28.09.2014, p. 621-626.

Research output: Contribution to journalArticle

Moussa, Hind N. ; Wu, Zhao Helen ; Han, Yimei ; Pacheco, Luis ; Blackwell, Sean C. ; Sibai, Baha M. ; Saade, George ; Costantine, Maged. / Customized versus population fetal growth norms and adverse outcomes associated with small for gestational age infants in a high-risk cohort. In: American Journal of Perinatology. 2014 ; Vol. 32, No. 7. pp. 621-626.
@article{5a847c662a9340ec81c7e3f476f9d6cc,
title = "Customized versus population fetal growth norms and adverse outcomes associated with small for gestational age infants in a high-risk cohort",
abstract = "Objective To compare population versus customized fetal growth norms in identifying neonates at risk for adverse perinatal and neonatal outcomes (AOs) associated with small for gestational age (SGA) in high-risk women. Design Secondary analysis to a multicenter treatment trial of pregnant women at high risk for preeclampsia using low-dose aspirin versus placebo. The associations between SGA by population (SGApop) and customized (SGAcust) norms and AOs were evaluated. Results A total of 2,289 mother/infant pairs were included in the analysis. The rates of SGA in the aspirin and placebo groups were similar by the customized (22.8{\%} vs 23.9{\%}; p=0.55) or population (8.7{\%} vs 7.5{\%}; p=0.54) norms; however, they were lower using population norms compared with customized norms (p<0.001). SGAcust, but not SGApop, was associated with spontaneous preterm birth (odds ratio [OR]: 1.44, 95{\%} confidence interval [CI]: 1.15-1.81; p<0.001), preterm premature rupture of membranes (OR 1.42 95{\%} CI 1.05-1.92; p=0.02), and cesarean delivery (OR: 1.35, 95{\%} CI: 1.11-1.64; p=0.002). Both SGAcust and SGApop were associated with the composite neonatal outcome, indicated preterm delivery before 32, 35, and 37 weeks, oligohydramnios, fetal distress, as well as decreased risk of oxygen requirement. Neither was associated with preeclampsia. Conclusion Customized approach for assessment of fetal growth was associated with higher SGA rates and better identification of SGA neonates at risk for AOs.",
keywords = "adverse outcomes, customized, fetal growth restriction, high risk",
author = "Moussa, {Hind N.} and Wu, {Zhao Helen} and Yimei Han and Luis Pacheco and Blackwell, {Sean C.} and Sibai, {Baha M.} and George Saade and Maged Costantine",
year = "2014",
month = "9",
day = "28",
doi = "10.1055/s-0034-1390343",
language = "English (US)",
volume = "32",
pages = "621--626",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "7",

}

TY - JOUR

T1 - Customized versus population fetal growth norms and adverse outcomes associated with small for gestational age infants in a high-risk cohort

AU - Moussa, Hind N.

AU - Wu, Zhao Helen

AU - Han, Yimei

AU - Pacheco, Luis

AU - Blackwell, Sean C.

AU - Sibai, Baha M.

AU - Saade, George

AU - Costantine, Maged

PY - 2014/9/28

Y1 - 2014/9/28

N2 - Objective To compare population versus customized fetal growth norms in identifying neonates at risk for adverse perinatal and neonatal outcomes (AOs) associated with small for gestational age (SGA) in high-risk women. Design Secondary analysis to a multicenter treatment trial of pregnant women at high risk for preeclampsia using low-dose aspirin versus placebo. The associations between SGA by population (SGApop) and customized (SGAcust) norms and AOs were evaluated. Results A total of 2,289 mother/infant pairs were included in the analysis. The rates of SGA in the aspirin and placebo groups were similar by the customized (22.8% vs 23.9%; p=0.55) or population (8.7% vs 7.5%; p=0.54) norms; however, they were lower using population norms compared with customized norms (p<0.001). SGAcust, but not SGApop, was associated with spontaneous preterm birth (odds ratio [OR]: 1.44, 95% confidence interval [CI]: 1.15-1.81; p<0.001), preterm premature rupture of membranes (OR 1.42 95% CI 1.05-1.92; p=0.02), and cesarean delivery (OR: 1.35, 95% CI: 1.11-1.64; p=0.002). Both SGAcust and SGApop were associated with the composite neonatal outcome, indicated preterm delivery before 32, 35, and 37 weeks, oligohydramnios, fetal distress, as well as decreased risk of oxygen requirement. Neither was associated with preeclampsia. Conclusion Customized approach for assessment of fetal growth was associated with higher SGA rates and better identification of SGA neonates at risk for AOs.

AB - Objective To compare population versus customized fetal growth norms in identifying neonates at risk for adverse perinatal and neonatal outcomes (AOs) associated with small for gestational age (SGA) in high-risk women. Design Secondary analysis to a multicenter treatment trial of pregnant women at high risk for preeclampsia using low-dose aspirin versus placebo. The associations between SGA by population (SGApop) and customized (SGAcust) norms and AOs were evaluated. Results A total of 2,289 mother/infant pairs were included in the analysis. The rates of SGA in the aspirin and placebo groups were similar by the customized (22.8% vs 23.9%; p=0.55) or population (8.7% vs 7.5%; p=0.54) norms; however, they were lower using population norms compared with customized norms (p<0.001). SGAcust, but not SGApop, was associated with spontaneous preterm birth (odds ratio [OR]: 1.44, 95% confidence interval [CI]: 1.15-1.81; p<0.001), preterm premature rupture of membranes (OR 1.42 95% CI 1.05-1.92; p=0.02), and cesarean delivery (OR: 1.35, 95% CI: 1.11-1.64; p=0.002). Both SGAcust and SGApop were associated with the composite neonatal outcome, indicated preterm delivery before 32, 35, and 37 weeks, oligohydramnios, fetal distress, as well as decreased risk of oxygen requirement. Neither was associated with preeclampsia. Conclusion Customized approach for assessment of fetal growth was associated with higher SGA rates and better identification of SGA neonates at risk for AOs.

KW - adverse outcomes

KW - customized

KW - fetal growth restriction

KW - high risk

UR - http://www.scopus.com/inward/record.url?scp=84930211500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930211500&partnerID=8YFLogxK

U2 - 10.1055/s-0034-1390343

DO - 10.1055/s-0034-1390343

M3 - Article

VL - 32

SP - 621

EP - 626

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 7

ER -